Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

DNA interference by a mesophilic Argonaute protein, CbcAgo

Identifieur interne : 000C66 ( Pmc/Curation ); précédent : 000C65; suivant : 000C67

DNA interference by a mesophilic Argonaute protein, CbcAgo

Auteurs : Nieves García-Quintans [Espagne] ; Laurie Bowden [Espagne] ; José Berenguer [Espagne] ; Mario Mencía [Espagne]

Source :

RBID : PMC:6961421

Abstract

Background: The search for putative enzymes that can facilitate gene editing has recently focused its attention on Argonaute proteins from prokaryotes (pAgos). Though they are structural homologues of human Argonaute protein, which uses RNA guides to interfere with RNA targets, pAgos use ssDNA guides to identify and, in many cases, cut a complementary DNA target. Thermophilic pAgos from Thermus thermophilus, Pyrococcus furiosus and Methanocaldococcus jasmanii have been identified and thoroughly studied, but their thermoactivity makes them of little use in mesophilic systems such as mammalian cells.

Methods: Here we search for and identify CbcAgo, a prokaryotic Argonaute protein from a mesophilic bacterium, and characterize in vitro its DNA interference activity.

Results: CbcAgo efficiently uses 5’P-ssDNA guides as small as 11-mers to cut ssDNA targets, requires divalent cations (preferentially, Mn 2+) and has a maximum activity between 37 and 42 °C, remaining active up to 55 °C. Nicking activity on supercoiled dsDNA was shown. However, no efficient double-strand breaking activity could be demonstrated.

Conclusions: CbcAgo can use gDNA guides as small as 11 nucleotides long to cut complementary ssDNA targets at 37ºC, making it a promising starting point for the development of new gene editing tools  for mammalian cells.


Url:
DOI: 10.12688/f1000research.18445.2
PubMed: 32055395
PubMed Central: 6961421

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:6961421

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">DNA interference by a mesophilic Argonaute protein, CbcAgo</title>
<author>
<name sortKey="Garcia Quintans, Nieves" sort="Garcia Quintans, Nieves" uniqKey="Garcia Quintans N" first="Nieves" last="García-Quintans">Nieves García-Quintans</name>
<affiliation wicri:level="1">
<nlm:aff id="a1">Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid-Consejo Superior de Investigaciones Científicas, Madrid, Madrid, 28049, Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid-Consejo Superior de Investigaciones Científicas, Madrid, Madrid, 28049</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Bowden, Laurie" sort="Bowden, Laurie" uniqKey="Bowden L" first="Laurie" last="Bowden">Laurie Bowden</name>
<affiliation wicri:level="1">
<nlm:aff id="a1">Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid-Consejo Superior de Investigaciones Científicas, Madrid, Madrid, 28049, Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid-Consejo Superior de Investigaciones Científicas, Madrid, Madrid, 28049</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Berenguer, Jose" sort="Berenguer, Jose" uniqKey="Berenguer J" first="José" last="Berenguer">José Berenguer</name>
<affiliation wicri:level="1">
<nlm:aff id="a1">Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid-Consejo Superior de Investigaciones Científicas, Madrid, Madrid, 28049, Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid-Consejo Superior de Investigaciones Científicas, Madrid, Madrid, 28049</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Mencia, Mario" sort="Mencia, Mario" uniqKey="Mencia M" first="Mario" last="Mencía">Mario Mencía</name>
<affiliation wicri:level="1">
<nlm:aff id="a1">Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid-Consejo Superior de Investigaciones Científicas, Madrid, Madrid, 28049, Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid-Consejo Superior de Investigaciones Científicas, Madrid, Madrid, 28049</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">32055395</idno>
<idno type="pmc">6961421</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961421</idno>
<idno type="RBID">PMC:6961421</idno>
<idno type="doi">10.12688/f1000research.18445.2</idno>
<date when="2020">2020</date>
<idno type="wicri:Area/Pmc/Corpus">000C66</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000C66</idno>
<idno type="wicri:Area/Pmc/Curation">000C66</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000C66</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">DNA interference by a mesophilic Argonaute protein, CbcAgo</title>
<author>
<name sortKey="Garcia Quintans, Nieves" sort="Garcia Quintans, Nieves" uniqKey="Garcia Quintans N" first="Nieves" last="García-Quintans">Nieves García-Quintans</name>
<affiliation wicri:level="1">
<nlm:aff id="a1">Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid-Consejo Superior de Investigaciones Científicas, Madrid, Madrid, 28049, Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid-Consejo Superior de Investigaciones Científicas, Madrid, Madrid, 28049</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Bowden, Laurie" sort="Bowden, Laurie" uniqKey="Bowden L" first="Laurie" last="Bowden">Laurie Bowden</name>
<affiliation wicri:level="1">
<nlm:aff id="a1">Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid-Consejo Superior de Investigaciones Científicas, Madrid, Madrid, 28049, Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid-Consejo Superior de Investigaciones Científicas, Madrid, Madrid, 28049</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Berenguer, Jose" sort="Berenguer, Jose" uniqKey="Berenguer J" first="José" last="Berenguer">José Berenguer</name>
<affiliation wicri:level="1">
<nlm:aff id="a1">Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid-Consejo Superior de Investigaciones Científicas, Madrid, Madrid, 28049, Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid-Consejo Superior de Investigaciones Científicas, Madrid, Madrid, 28049</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Mencia, Mario" sort="Mencia, Mario" uniqKey="Mencia M" first="Mario" last="Mencía">Mario Mencía</name>
<affiliation wicri:level="1">
<nlm:aff id="a1">Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid-Consejo Superior de Investigaciones Científicas, Madrid, Madrid, 28049, Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid-Consejo Superior de Investigaciones Científicas, Madrid, Madrid, 28049</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">F1000Research</title>
<idno type="eISSN">2046-1402</idno>
<imprint>
<date when="2020">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<bold>Background</bold>
: The search for putative enzymes that can facilitate gene editing has recently focused its attention on Argonaute proteins from prokaryotes (pAgos). Though they are structural homologues of human Argonaute protein, which uses RNA guides to interfere with RNA targets, pAgos use ssDNA guides to identify and, in many cases, cut a complementary DNA target. Thermophilic pAgos from
<italic>Thermus thermophilus</italic>
,
<italic>Pyrococcus furiosus</italic>
and
<italic>Methanocaldococcus jasmanii</italic>
have been identified and thoroughly studied, but their thermoactivity makes them of little use in mesophilic systems such as mammalian cells.</p>
<p>
<bold>Methods</bold>
: Here we search for and identify CbcAgo, a prokaryotic Argonaute protein from a mesophilic bacterium, and characterize
<italic>in vitro</italic>
its DNA interference activity.</p>
<p>
<bold>Results</bold>
: CbcAgo efficiently uses 5’P-ssDNA guides as small as 11-mers to cut ssDNA targets, requires divalent cations (preferentially, Mn
<sup>2+</sup>
) and has a maximum activity between 37 and 42 °C, remaining active up to 55 °C. Nicking activity on supercoiled dsDNA was shown. However, no efficient double-strand breaking activity could be demonstrated.</p>
<p>
<bold>Conclusions</bold>
: CbcAgo can use gDNA guides as small as 11 nucleotides long to cut complementary ssDNA targets at 37ºC, making it a promising starting point for the development of new gene editing tools  for mammalian cells.</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct>
<analytic>
<author>
<name sortKey="Meister, G" uniqKey="Meister G">G Meister</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Swarts, Dc" uniqKey="Swarts D">DC Swarts</name>
</author>
<author>
<name sortKey="Makarova, K" uniqKey="Makarova K">K Makarova</name>
</author>
<author>
<name sortKey="Wang, Y" uniqKey="Wang Y">Y Wang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Swarts, Dc" uniqKey="Swarts D">DC Swarts</name>
</author>
<author>
<name sortKey="Jore, Mm" uniqKey="Jore M">MM Jore</name>
</author>
<author>
<name sortKey="Westra, Er" uniqKey="Westra E">ER Westra</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Swarts, Dc" uniqKey="Swarts D">DC Swarts</name>
</author>
<author>
<name sortKey="Hegge, Jw" uniqKey="Hegge J">JW Hegge</name>
</author>
<author>
<name sortKey="Hinojo, I" uniqKey="Hinojo I">I Hinojo</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Zander, A" uniqKey="Zander A">A Zander</name>
</author>
<author>
<name sortKey="Willkomm, S" uniqKey="Willkomm S">S Willkomm</name>
</author>
<author>
<name sortKey="Ofer, S" uniqKey="Ofer S">S Ofer</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Yuan, Yr" uniqKey="Yuan Y">YR Yuan</name>
</author>
<author>
<name sortKey="Pei, Y" uniqKey="Pei Y">Y Pei</name>
</author>
<author>
<name sortKey="Ma, Jb" uniqKey="Ma J">JB Ma</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sunghyeok, Y" uniqKey="Sunghyeok Y">Y Sunghyeok</name>
</author>
<author>
<name sortKey="Taegeun, B" uniqKey="Taegeun B">B Taegeun</name>
</author>
<author>
<name sortKey="Kyoungmi, K" uniqKey="Kyoungmi K">K Kyoungmi,</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Olovnikov, I" uniqKey="Olovnikov I">I Olovnikov</name>
</author>
<author>
<name sortKey="Chan, K" uniqKey="Chan K">K Chan</name>
</author>
<author>
<name sortKey="Sachidanandam, R" uniqKey="Sachidanandam R">R Sachidanandam</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sheng, G" uniqKey="Sheng G">G Sheng</name>
</author>
<author>
<name sortKey="Zhao, H" uniqKey="Zhao H">H Zhao</name>
</author>
<author>
<name sortKey="Wang, J" uniqKey="Wang J">J Wang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Swarts, Dc" uniqKey="Swarts D">DC Swarts</name>
</author>
<author>
<name sortKey="Szczepaniak, M" uniqKey="Szczepaniak M">M Szczepaniak</name>
</author>
<author>
<name sortKey="Sheng, G" uniqKey="Sheng G">G Sheng</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hegge, Jw" uniqKey="Hegge J">JW Hegge</name>
</author>
<author>
<name sortKey="Swarts, Dc" uniqKey="Swarts D">DC Swarts</name>
</author>
<author>
<name sortKey="Van Der Oost, J" uniqKey="Van Der Oost J">J van der Oost</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gao, F" uniqKey="Gao F">F Gao</name>
</author>
<author>
<name sortKey="Shen, Xz" uniqKey="Shen X">XZ Shen</name>
</author>
<author>
<name sortKey="Jiang, F" uniqKey="Jiang F">F Jiang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lee, Sh" uniqKey="Lee S">SH Lee</name>
</author>
<author>
<name sortKey="Turchiano, G" uniqKey="Turchiano G">G Turchiano</name>
</author>
<author>
<name sortKey="Ata, H" uniqKey="Ata H">H Ata</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hegge, Jw" uniqKey="Hegge J">JW Hegge</name>
</author>
<author>
<name sortKey="Swarts, Dc" uniqKey="Swarts D">DC Swarts</name>
</author>
<author>
<name sortKey="Chandradoss, Sd" uniqKey="Chandradoss S">SD Chandradoss</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kuzmenko, A" uniqKey="Kuzmenko A">A Kuzmenko</name>
</author>
<author>
<name sortKey="Yudin, D" uniqKey="Yudin D">D Yudin</name>
</author>
<author>
<name sortKey="Ryazansky, S" uniqKey="Ryazansky S">S Ryazansky</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Wang, Y" uniqKey="Wang Y">Y Wang</name>
</author>
<author>
<name sortKey="Sheng, G" uniqKey="Sheng G">G Sheng</name>
</author>
<author>
<name sortKey="Juranek, S" uniqKey="Juranek S">S Juranek</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Berenguer, J" uniqKey="Berenguer J">J Berenguer</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="research-article">
<pmc-dir>properties open_access</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">F1000Res</journal-id>
<journal-id journal-id-type="iso-abbrev">F1000Res</journal-id>
<journal-id journal-id-type="pmc">F1000Research</journal-id>
<journal-title-group>
<journal-title>F1000Research</journal-title>
</journal-title-group>
<issn pub-type="epub">2046-1402</issn>
<publisher>
<publisher-name>F1000 Research Limited</publisher-name>
<publisher-loc>London, UK</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32055395</article-id>
<article-id pub-id-type="pmc">6961421</article-id>
<article-id pub-id-type="doi">10.12688/f1000research.18445.2</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>DNA interference by a mesophilic Argonaute protein, CbcAgo</article-title>
<fn-group content-type="pub-status">
<fn>
<p>[version 2; peer review: 2 approved]</p>
</fn>
</fn-group>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>García-Quintans</surname>
<given-names>Nieves</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bowden</surname>
<given-names>Laurie</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Berenguer</surname>
<given-names>José</given-names>
</name>
<role content-type="http://credit.casrai.org/">Funding Acquisition</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – Original Draft Preparation</role>
<role content-type="http://credit.casrai.org/">Writing – Review & Editing</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9689-6272</contrib-id>
<xref ref-type="corresp" rid="c1">a</xref>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mencía</surname>
<given-names>Mario</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – Review & Editing</role>
<xref ref-type="corresp" rid="c2">b</xref>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<aff id="a1">
<label>1</label>
Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid-Consejo Superior de Investigaciones Científicas, Madrid, Madrid, 28049, Spain</aff>
</contrib-group>
<author-notes>
<corresp id="c1">
<label>a</label>
<email xlink:href="mailto:jberenguer@cbm.csic.es">jberenguer@cbm.csic.es</email>
</corresp>
<corresp id="c2">
<label>b</label>
<email xlink:href="mailto:mmencia@cbm.csic.es">mmencia@cbm.csic.es</email>
</corresp>
<fn fn-type="COI-statement">
<p>No competing interests were disclosed.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>9</day>
<month>1</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>8</volume>
<elocation-id>321</elocation-id>
<history>
<date date-type="accepted">
<day>3</day>
<month>1</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: © 2020 García-Quintans N et al.</copyright-statement>
<copyright-year>2020</copyright-year>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="f1000research-8-24144.pdf"></self-uri>
<abstract>
<p>
<bold>Background</bold>
: The search for putative enzymes that can facilitate gene editing has recently focused its attention on Argonaute proteins from prokaryotes (pAgos). Though they are structural homologues of human Argonaute protein, which uses RNA guides to interfere with RNA targets, pAgos use ssDNA guides to identify and, in many cases, cut a complementary DNA target. Thermophilic pAgos from
<italic>Thermus thermophilus</italic>
,
<italic>Pyrococcus furiosus</italic>
and
<italic>Methanocaldococcus jasmanii</italic>
have been identified and thoroughly studied, but their thermoactivity makes them of little use in mesophilic systems such as mammalian cells.</p>
<p>
<bold>Methods</bold>
: Here we search for and identify CbcAgo, a prokaryotic Argonaute protein from a mesophilic bacterium, and characterize
<italic>in vitro</italic>
its DNA interference activity.</p>
<p>
<bold>Results</bold>
: CbcAgo efficiently uses 5’P-ssDNA guides as small as 11-mers to cut ssDNA targets, requires divalent cations (preferentially, Mn
<sup>2+</sup>
) and has a maximum activity between 37 and 42 °C, remaining active up to 55 °C. Nicking activity on supercoiled dsDNA was shown. However, no efficient double-strand breaking activity could be demonstrated.</p>
<p>
<bold>Conclusions</bold>
: CbcAgo can use gDNA guides as small as 11 nucleotides long to cut complementary ssDNA targets at 37ºC, making it a promising starting point for the development of new gene editing tools  for mammalian cells.</p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>Argonaute</kwd>
<kwd>prokaryotic</kwd>
<kwd>mesophilic</kwd>
<kwd>gene edition</kwd>
<kwd>characterization</kwd>
<kwd>DNA-DNA interference</kwd>
</kwd-group>
<funding-group>
<award-group id="fund-1">
<funding-source>Spanish Ministry of Economy and Competitiveness</funding-source>
<award-id>BIO2016-77031-R</award-id>
</award-group>
<award-group id="fund-2" xlink:href="http://dx.doi.org/10.13039/100008054">
<funding-source>Fundación Ramón Areces</funding-source>
<award-id>Institutionalgrant</award-id>
</award-group>
<funding-statement>This work was supported by a grant from the Spanish Ministry of Economy and Competitiveness [BIO2016-77031-R] to J. Berenguer. An institutional grant from Fundación Ramón Areces to the CBMSO is also acknowledged.</funding-statement>
<funding-statement>
<italic>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</italic>
</funding-statement>
</funding-group>
</article-meta>
<notes notes-type="version-changes">
<sec sec-type="version-changes">
<label>Revised</label>
<title>Amendments from Version 1</title>
<p>Most of the changes included in the new version are intended to actualize the article in relation with the already published articles of Hedgge
<italic>et al</italic>
and Kuzmenko
<italic>et al</italic>
describing a similar pAgo from other strain from
<italic>Clostridium butyricum</italic>
, only one of which (Hedgge et al) was posted as unrevised article when the first version of this article was sent.  Basically, the differences that we reported at the level of thermostability of CbcAgo in comparison with that of CbcAgo have been reconsidered once known the results of Kuzmenko
<italic>et al</italic>
reporting also a higher thermostability for their tagged version of CbAgo. Other minor changes are related with the proper alignment of the numbering of the figures, or an increase in the size of the lettering for an easier reading.  The Discussion section has been also modified to provide appropriate answers to the reviewers comments, included in the corresponding section.</p>
</sec>
</notes>
</front>
<sub-article id="report58429" article-type="peer-review">
<front-stub>
<article-id pub-id-type="doi">10.5256/f1000research.24144.r58429</article-id>
<title-group>
<article-title>Reviewer response for version 2</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tanner</surname>
<given-names>Nathan A.</given-names>
</name>
<xref ref-type="aff" rid="r58429a1">1</xref>
<role>Referee</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7601-7077</contrib-id>
</contrib>
<aff id="r58429a1">
<label>1</label>
New England Biolabs, Ipswich, Massachusetts, USA</aff>
</contrib-group>
<author-notes>
<fn fn-type="COI-statement">
<p>
<bold>Competing interests: </bold>
No competing interests were disclosed.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>1</month>
<year>2020</year>
</pub-date>
<permissions>
<copyright-statement>Copyright: © 2020 Tanner NA</copyright-statement>
<copyright-year>2020</copyright-year>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article related-article-type="peer-reviewed-article" id="d35e2196" ext-link-type="doi" xlink:href="10.12688/f1000research.18445.2">Version 2</related-article>
<custom-meta-group>
<custom-meta>
<meta-name>recommendation</meta-name>
<meta-value>approve</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>The authors addressed the major points of criticism from the original submission, with updates and additions to discuss the newer publication and discrepancies with this work. The unusual results and findings at odds with other CbAgo papers are discussed more, adding to the ability of the reader to consider this work in the field. I'd still suggest some different presentation on some of the data figures but the authors disagree and have supplemental versions with fuller images, so this can be attributed to a matter of preference. I feel the revised version is stronger and sufficient for indexing.</p>
<p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p>
</body>
</sub-article>
<sub-article id="report58430" article-type="peer-review">
<front-stub>
<article-id pub-id-type="doi">10.5256/f1000research.24144.r58430</article-id>
<title-group>
<article-title>Reviewer response for version 2</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Santero</surname>
<given-names>Eduardo</given-names>
</name>
<xref ref-type="aff" rid="r58430a2">2</xref>
<role>Referee</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6111-7160</contrib-id>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Canosa</surname>
<given-names>Inés</given-names>
</name>
<xref ref-type="aff" rid="r58430a1">1</xref>
<role>Co-referee</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5883-9728</contrib-id>
</contrib>
<aff id="r58430a1">
<label>1</label>
University Pablo de Olavide, Seville, Spain</aff>
<aff id="r58430a2">
<label>2</label>
Andalusian Center for Developmental Biology (CABD), Superior Council of Scientific Investigations (CSIC), Council of Andalusia, Pablo de Olavide University, Seville, Spain</aff>
</contrib-group>
<author-notes>
<fn fn-type="COI-statement">
<p>
<bold>Competing interests: </bold>
No competing interests were disclosed.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>1</month>
<year>2020</year>
</pub-date>
<permissions>
<copyright-statement>Copyright: © 2020 Canosa I and Santero E</copyright-statement>
<copyright-year>2020</copyright-year>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article related-article-type="peer-reviewed-article" id="d35e2272" ext-link-type="doi" xlink:href="10.12688/f1000research.18445.2">Version 2</related-article>
<custom-meta-group>
<custom-meta>
<meta-name>recommendation</meta-name>
<meta-value>approve</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>I think authors have satisfactorily dealt with the reviewers comments and, therefore, I have no further comments on the revised version of the manuscript</p>
<p>We confirm that we have read this submission and believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p>
</body>
</sub-article>
<sub-article id="report51940" article-type="peer-review">
<front-stub>
<article-id pub-id-type="doi">10.5256/f1000research.20180.r51940</article-id>
<title-group>
<article-title>Reviewer response for version 1</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tanner</surname>
<given-names>Nathan A.</given-names>
</name>
<xref ref-type="aff" rid="r51940a1">1</xref>
<role>Referee</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7601-7077</contrib-id>
</contrib>
<aff id="r51940a1">
<label>1</label>
New England Biolabs, Ipswich, Massachusetts, USA</aff>
</contrib-group>
<author-notes>
<fn fn-type="COI-statement">
<p>
<bold>Competing interests: </bold>
No competing interests were disclosed.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>2</day>
<month>8</month>
<year>2019</year>
</pub-date>
<permissions>
<copyright-statement>Copyright: © 2019 Tanner NA</copyright-statement>
<copyright-year>2019</copyright-year>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article related-article-type="peer-reviewed-article" id="d35e2331" ext-link-type="doi" xlink:href="10.12688/f1000research.18445.1">Version 1</related-article>
<custom-meta-group>
<custom-meta>
<meta-name>recommendation</meta-name>
<meta-value>approve-with-reservations</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>The study from Garcia-Quintans
<italic>et al.</italic>
looks at a new pAgo protein from Clostridium and investigates factors influencing its cleavage activity on DNA substrates. The
<italic> in vitro</italic>
activity is characterized pretty well, but there are some serious issues I find with the data and its presentation, as well as the contradictory findings of another recent publication.
<list list-type="order">
<list-item>
<p>The authors report a significant (by eye ~40%) contaminant of an N-terminal truncation at about half the size of the expected protein (Figure 1). I would assume this is an inactive form of the enzyme, but does it still bind guides? Bind to DNA targets? Perhaps affect the results of all the experiments in the paper? This should be addressed in more detail, and ideally cleaned up (along with the GroEL contaminat) using another chromatography step.</p>
</list-item>
<list-item>
<p>Most of the gels are shown as zoomed in cropped sections of the gel. I feel these should instead show the whole, or at least more of, the gel, and include low-molecular weight marker standards. Some gels have oligonucleotide standards but the resolution is very poor in terms of distinguishing between a few bases (I'd suggest moving the guides by more than 1 base). And as shown in Figure 8 11 ntd ssDNA can clearly be seen, but where is it in the other gels where the product should be 2 ssDNA's? The most problematic is Figure 5 where the far right gel is too poor for publication, and seems to show production of P species without added guide at 55C? Where is the guide in all those wells? Figure 8 seems to have additional bands between P and guide, Figure 10 has an unidentified high molecular weight species, and the size markers in Figure 7 should be labeled more clearly. </p>
</list-item>
<list-item>
<p>I feel there should be more explanation given to the (to me) bizarre finding that a 7 or 9 base guide can cut at the +10/11 position...which of course does not have a guided complement. How do the authors think this can happen?</p>
</list-item>
<list-item>
<p>The authors mention the Hegge
<italic>et al.</italic>
, preprint, which they should, but that paper was published in NAR after this study. And importantly, so was another study with CbAgo, from a strain mentioned here (Kuzmenko
<italic>et al.</italic>
<sup>
<xref rid="rep-ref-51940-1" ref-type="bibr">1</xref>
</sup>
). In this study, the authors show several things at odds with the current work: no cleavage with 10 or 12-base guides even after 24hr incubation, activity to 60C, ability to use 5'-OH guides, the ability to cut dsDNA with opposite strand guides at 37C in 1-4h, and with moderate (500 nM) concentrations of CbAgo a chopping activity on plasmid DNA. It is likely this work was not available at the time the reviewed study was published, but it is difficult to ignore the contradictions now. It is possible that the Cb/CbcAgo protein is exactly the same in all 3 studies, and these discrepancies are significant for the conclusions presented here.</p>
</list-item>
<list-item>
<p>Related, I'd expect there to be some plasmid chopping given the time and concentrations the authors describe. But no Apo reactions are shown in Figure 10, an important control that is left out. And a comparison of attempts to digest non-supercoiled plasmid would be good for the explanation that dsDNA cannot be accessed w/o supercoiling.</p>
</list-item>
<list-item>
<p>Minor points, but there are some errors ("xilencyanol", "ImajeJ) and inconsistencies (PfAgo/PfuAgo) that should be fixed.</p>
</list-item>
</list>
</p>
<p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="rep-ref-51940-1">
<label>1</label>
<mixed-citation publication-type="journal">:
<article-title>Programmable DNA cleavage by Ago nucleases from mesophilic bacteria Clostridium butyricum and Limnothrix rosea.</article-title>
<source>
<italic toggle="yes">Nucleic Acids Res</italic>
</source>
.
<year>2019</year>
;
<volume>47</volume>
(
<issue>11</issue>
) :
<elocation-id>10.1093/nar/gkz379</elocation-id>
<fpage>5822</fpage>
-
<lpage>5836</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkz379</pub-id>
<pub-id pub-id-type="pmid">31114878</pub-id>
</mixed-citation>
</ref>
</ref-list>
</back>
<sub-article id="comment5127" article-type="response">
<front-stub>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Berenguer</surname>
<given-names>Jose</given-names>
</name>
<aff>Universidad Autónoma de Madrid, Spain</aff>
</contrib>
</contrib-group>
<author-notes>
<fn fn-type="COI-statement">
<p>
<bold>Competing interests: </bold>
No competing interst to report</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>23</day>
<month>12</month>
<year>2019</year>
</pub-date>
</front-stub>
<body>
<p>
<bold>Reviewer  2</bold>
</p>
<p> García-Quintans et al. reports on the identification of an Argonaute protein coding gene from the mesophilic bacterium
<italic>Clostridium butyricum</italic>
strain CWBI 1009, and characterise its product as a potential genome editing tool alternative to the well-known CRISPR/Cas. Authors have purified the native protein and an inactive variant as a control, and thoroughly characterise its activity in relation to a number of parameters such as different temperatures, cations and ionic strength. Altogether, the work of García-Quintans is a well-designed characterisation of the in vitro activity of the CbcAgo protein.</p>
<p> A similar work has been recently published in Nucleic Acids Research1, by the group of John van der Oost using a similar CbAgo protein from an unspecified strain of C. butyricum, as acknowledged by the authors. It appears that both proteins have very similar characteristics.</p>
<p> The authors claim some relevant differences between both proteins:</p>
<p>
<bold>Enzyme stability at different temperatures:</bold>
In first place, none of authors assay thermostability, they assay activity at different temperatures, which is not the same. This should be changed in the Discussion, pg. 10. Based on the partial activity detected at 55°C in this paper, authors claim CbcAgo might be more “stable” than CbAgo (Discussion, pg. 10). However, CbAgo activity was not assayed at 55°C but at 50°C (partially active) and 64°C (inactive). A comparison of the activities at the same temperature, 50°C, which show almost maximal activity of CbcAgo but substantially reduced activity of CbAgo (<50%), would be more reliable. Anyways, since the difference is very small, it is very difficult to ascertain whether the differences are real or a consequence of slightly different assay conditions.</p>
<p>
<italic>Answer:</italic>
</p>
<p>
<italic>In a further article by Kuzmenko et all, the CbAgo protein shows nuclease activity up to 60ºC, so the apparent thermostability differences are more likely due to the experimental settings used than to the protein sequence itself. We have modified the discussion accordingly just saying that the apparent activity at high temperature is higher under our experimental conditions, but that due to differences in the assays (dDNA and tDNA) the data cannot be directly compared</italic>
</p>
<p>
<bold>Strict dependence on phosphorylation:</bold>
Both CbAgo and CbcAgo, were unable to cut a short 45-mer target DNA if the gDNA is 5’-OH. However, Hegge et al., 20191, additionally reported partial activity of CbAgo on a longer target (120-mer), which was not tested in this manuscript. Therefore, in this regard, there is no data that supports the difference between both proteins claimed in this manuscript.</p>
<p>
<italic>Answer:</italic>
</p>
<p>
<italic>This has been already commented as answer to point 4 raised by reviewer  1. We agree in that even for the CbAgo it is more likely to use a 5’P gDNA than an 5’-OH one, as i) they are less active in the best of the cases than  5’-P counterparts, and ii) the binding site at the MID domain shows several contacts between the 5’P extreme of the gDNA and residues in the protein, supporting a higher affinity for this type of substrates than for  5’OH ones.  The differences found are more likely due to differences in the experimental setting, including the selection of the substrates and the hybridization position.</italic>
</p>
<p>
<bold>Minimum size length of the gDNA:</bold>
By comparing the results obtained with both proteins, it is apparent that CbcArgo requires a shorter gDNA to cleave the target. I think this is the most evident difference. However, as the authors acknowledge, these differences may be due to technical reasons rather than a difference in catalytic activity between the Argo proteins. The question of whether CbcArgo and CbArgo show any difference in activity could only be solved by making a side by side comparison of both proteins having the same tag, and using exactly the same procedure.</p>
<p> Anyways, I really miss an alignment of CbAgo and CbcAgo proteins to know how different these proteins are at the amino acid level.</p>
<p>
<italic>Answer:</italic>
</p>
<p>
<italic>Proteins CbAgo (used in the articles of Hedgge et al and Kuzmenko et al and CbcAgo (Used in this article) are very similar. From the 748 amino acids of the three protein only 12 differences exist: N188D, D191G, R200K, S204A, E212K, K216N, S217T, E220D, K253N, K258Q, I343V, S466L, being the first position corresponding to the CbAgo and the second to the CbcAgo.  These changes  are located mainly at inter-domain  regions and could be not too relevant for the activity but could affect parameters such as stability.  Additional differences in the results between both proteins could be due to the presence or absence of tags (Strep-tag in CbcAgo, His-tag in Kuzmenko´s  CbAgo and no tags in Heddge`s CbAgo).</italic>
</p>
<p> Other comments:</p>
<p> Please, properly align lanes and lanes names/numbers in Fig. 1.</p>
<p>
<italic>Answer:</italic>
</p>
<p>
<italic>OK, done</italic>
</p>
<p> Requirement for 5´phosphorylated gDNA is shown in Fig. 6, not 4 (Discussion, pg. 10).</p>
<p>
<italic>Answer:</italic>
</p>
<p>
<italic>OK, Modified</italic>
</p>
<p>
<italic>Answer:</italic>
</p>
<p>
<italic>Actualized references included in the text:</italic>
</p>
<p>
<italic>Hegge, J. W. et al. DNA-guided DNA cleavage at moderate temperatures by Clostridium butyricum Argonaute.
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/31069393">Nucleic Acids Res.</ext-link>
</italic>
<italic> 47, 5809-5821. doi: 10.1093/nar/gkz306.(2019).</italic>
</p>
<p>
<italic>Kuzmenko, A.,  Yudin, D.,  Ryazansky, Kulbachinskiy, S. A. & Aravin, A. A.  Programmable DNA cleavage by Ago nucleases from mesophilic bacteria Clostridium butyricum and Limnothrix rose. Nucleic Acids Res.
<bold>47</bold>
, 5822–5836 doi: 10.1093/nar/gkz379 (2019)</italic>
</p>
</body>
</sub-article>
</sub-article>
<sub-article id="report51304" article-type="peer-review">
<front-stub>
<article-id pub-id-type="doi">10.5256/f1000research.20180.r51304</article-id>
<title-group>
<article-title>Reviewer response for version 1</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Santero</surname>
<given-names>Eduardo</given-names>
</name>
<xref ref-type="aff" rid="r51304a1">1</xref>
<role>Referee</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6111-7160</contrib-id>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Canosa</surname>
<given-names>Inés</given-names>
</name>
<xref ref-type="aff" rid="r51304a2">2</xref>
<role>Co-referee</role>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5883-9728</contrib-id>
</contrib>
<aff id="r51304a1">
<label>1</label>
Andalusian Center for Developmental Biology (CABD), Superior Council of Scientific Investigations (CSIC), Council of Andalusia, Pablo de Olavide University, Seville, Spain</aff>
<aff id="r51304a2">
<label>2</label>
University Pablo de Olavide, Seville, Spain</aff>
</contrib-group>
<author-notes>
<fn fn-type="COI-statement">
<p>
<bold>Competing interests: </bold>
No competing interests were disclosed.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>7</month>
<year>2019</year>
</pub-date>
<permissions>
<copyright-statement>Copyright: © 2019 Santero E and Canosa I</copyright-statement>
<copyright-year>2019</copyright-year>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article related-article-type="peer-reviewed-article" id="d35e2629" ext-link-type="doi" xlink:href="10.12688/f1000research.18445.1">Version 1</related-article>
<custom-meta-group>
<custom-meta>
<meta-name>recommendation</meta-name>
<meta-value>approve-with-reservations</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>García-Quintans
<italic>et al.</italic>
reports on the identification of an Argonaute protein coding gene from the mesophilic bacterium
<italic>Clostridium butyricum</italic>
strain CWBI 1009, and characterise its product as a potential genome editing tool alternative to the well known CRISPR/Cas. Authors have purified the native protein and an inactive variant as a control, and thoroughly characterise its activity in relation to a number of parameters such as different temperatures, cations and ionic strength. Altogether, the work of García-Quintans is a well-designed characterisation of the in vitro activity of the CbcAgo protein.</p>
<p> A similar work has been recently published in Nucleic Acids Research
<sup>
<xref rid="rep-ref-51304-1" ref-type="bibr">1</xref>
</sup>
, by the group of John van der Oost using a similar CbAgo protein from an unspecified strain of
<italic>C. butyricum</italic>
, as acknowledged by the authors. It appears that both proteins have very similar characteristics.</p>
<p> The authors claim some relevant differences between both proteins:</p>
<p>
<bold>Enzyme stability at different temperatures:</bold>
In first place, none of authors assay thermostability, they assay activity at different temperatures, which is not the same. This should be changed in the Discussion, pg. 10. Based on the partial activity detected at 55°C in this paper, authors claim CbcAgo might be more “stable” than CbAgo (Discussion, pg. 10). However, CbAgo activity was not assayed at 55°C but at 50°C (partially active) and 64°C (inactive). A comparison of the activities at the same temperature, 50°C, which show almost maximal activity of CbcAgo but substantially reduced activity of CbAgo (<50%), would be more reliable. Anyways, since the difference is very small, it is very difficult to ascertain whether the differences are real or a consequence of slightly different assay conditions.</p>
<p>
<bold>Strict dependence on phosphorylation:</bold>
Both CbAgo and CbcAgo, were unable to cut a short 45-mer target DNA if the gDNA is 5’-OH. However, Hegge
<italic>et al.</italic>
, 2019
<sup>
<xref rid="rep-ref-51304-1" ref-type="bibr">1</xref>
</sup>
, additionally reported partial activity of CbAgo on a longer target (120-mer), which was not tested in this manuscript. Therefore, in this regard, there is no data that supports the difference between both proteins claimed in this manuscript.</p>
<p>
<bold>Minimum size length of the gDNA:</bold>
By comparing the results obtained with both proteins, it is apparent that CbcArgo requires a shorter gDNA to cleave the target. I think this is the most evident difference. However, as the authors acknowledge, these differences may be due to technical reasons rather than a difference in catalytic activity between the Argo proteins. The question of whether CbcArgo and CbArgo show any difference in activity could only be solved by making a side by side comparison of both proteins having the same tag, and using exactly the same procedure.</p>
<p> Anyways, I really miss an alignment of CbArgo and CbcArgo proteins to know how different these proteins are at the amino acid level.</p>
<p>
<bold>Other comments:</bold>
</p>
<p> Please, properly align lanes and lanes names/numbers in Fig. 1.</p>
<p> Requirement for 5´phosphorylated gDNA is shown in Fig. 6, not 4 (Discussion, pg. 10).</p>
<p>We confirm that we have read this submission and believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however we have significant reservations, as outlined above.</p>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="rep-ref-51304-1">
<label>1</label>
<mixed-citation publication-type="journal">:
<article-title>DNA-guided DNA cleavage at moderate temperatures by Clostridium butyricum Argonaute.</article-title>
<source>
<italic toggle="yes">Nucleic Acids Res</italic>
</source>
.
<year>2019</year>
;
<volume>47</volume>
(
<issue>11</issue>
) :
<elocation-id>10.1093/nar/gkz306</elocation-id>
<fpage>5809</fpage>
-
<lpage>5821</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkz306</pub-id>
<pub-id pub-id-type="pmid">31069393</pub-id>
</mixed-citation>
</ref>
</ref-list>
</back>
<sub-article id="comment5126" article-type="response">
<front-stub>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Berenguer</surname>
<given-names>Jose</given-names>
</name>
<aff>Universidad Autónoma de Madrid, Spain</aff>
</contrib>
</contrib-group>
<author-notes>
<fn fn-type="COI-statement">
<p>
<bold>Competing interests: </bold>
No competing interest</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>23</day>
<month>12</month>
<year>2019</year>
</pub-date>
</front-stub>
<body>
<p>
<bold>Reviewer 1.</bold>
</p>
<p> The study from Garcia-Quintans et al. looks at a new pAgo protein from Clostridium and investigates factors influencing its cleavage activity on DNA substrates. The in vitro activity is characterized pretty well, but there are some serious issues I find with the data and its presentation, as well as the contradictory findings of another recent publication.</p>
<p> 1.            The authors report a significant (by eye ~40%) contaminant of an N-terminal truncation at about half the size of the expected protein (Figure 1). I would assume this is an inactive form of the enzyme, but does it still bind guides? Bind to DNA targets? Perhaps affect the results of all the experiments in the paper? This should be addressed in more detail, and ideally cleaned up (along with the GroEL contaminat) using another chromatography step.</p>
<p>
<italic>Answer:</italic>
</p>
<p>
<italic>As described in the article these contaminant proteins were systematically associated to the full length protein. The use of an inactive mutant cbAgo in which the N-terminal truncated fragment and the GroEL proteins were also co-purified guarantees that the observed activity on the target DNA in the presence of gDNA is exclusively due to the catalytic activity of the wt enzyme and not the result of hidden activity of the co-purified proteins. A series of different chromatographic steps have been tried, and in all cases separation of contaminants was not possible and/or the activity of the enzyme was diminished</italic>
</p>
<p>
<italic>However we agree in that N-terminal fragment could bind either target or gDNA, leading to a minor subestimation of the actual activity of the enzyme or the optimal ratio target:gDNA, but without affecting the conclusions shown in the article. </italic>
</p>
<p> 2.            Most of the gels are shown as zoomed in cropped sections of the gel. I feel these should instead show the whole, or at least more of, the gel, and include low-molecular weight marker standards. Some gels have oligonucleotide standards but the resolution is very poor in terms of distinguishing between a few bases (I'd suggest moving the guides by more than 1 base). And as shown in Figure 8 11 ntd ssDNA can clearly be seen, but where is it in the other gels where the product should be 2 ssDNA's? The most problematic is Figure 5 where the far right gel is too poor for publication, and seems to show production of P species without added guide at 55C? Where is the guide in all those wells? Figure 8 seems to have additional bands between P and guide, Figure 10 has an unidentified high molecular weight species, and the size markers in Figure 7 should be labeled more clearly.</p>
<p>
<italic>Answer:</italic>
</p>
<p>
<italic>Due to requirements for organizing easy-to-follow figures, the images are cropped, as most figures in articles in the field are. However, as described in the article, the original full size images of all the gels used are accessible for detailed analysis at https://doi.org/10.17605/OSF.IO/8GQUZ </italic>
</p>
<p>
<italic>Regarding gel resolution, we do not agree with the reviewer. Under the conditions used a single base makes a difference in the detected mobility of the gDNA and products, and our interest of using base-to –base changes was to be sure that we were able to move the cutting site in the tDNA in a precise manner (i.e. figs 7,  9). As there are so many size markers, only those closer to the size of the products were indicated, but likely the size of the numbers is too small for readers and are increased in the  revised version.</italic>
</p>
<p>
<italic>Regarding Fig 8, as the reviewer comments the reaction generates two ssDNA products from the tDNA.  The  largest one is 40 mer and is detected and  labelled as P in the figures, and this is also the most adequate fragment for comparison. The small one is only 10 mer long (at the 3’ extreme of the tDNA) and escapes from the standard gels (lane 11 in Fig 8 shows the 11mer gDNA at the bottom of the gel). Also, in the other figures the small tDNA product moves out of the gels due to its small size. </italic>
</p>
<p>
<italic>In figure 8, the reviewer points to the presence of minor bands below the main 40 mer product, especially under the lanes labelled 11 and 13.  We cannot be sure of their origin but could correspond to lower affinity matches of the guides (11 and 13 mer) with the tDNA, as they are not detected with longer guides. </italic>
</p>
<p>
<italic>Regarding figure 5, the reviewer is right. The line indicating absence (-) or presence (+) of guides have contracted during the figure assembly and it apparently seems that the enzyme cuts without guide at 50 and 55 ºC, but it is not that way.  In the gel at right,  the left lanes below each temperature (55,  60, 65 and 70 ºC) corresponds to assays without gDNA and the right one with gDNA (detected at the gel bottom), whereas in the  left and central panels is first with (+) and then without (-) .  In all cases, the product is only detected when the guide is present.  This figure will be modified to correct the alignment of the labellings.</italic>
</p>
<p>
<italic>Respect to Fig. 10, the high molecular size  species detected could be concatenated plasmids, as it was detected in the untreated plasmid preparation (lane 5) and in the open circle treatment  (lane 7) but not in the linear form (lane 6).</italic>
</p>
<p> 3.            I feel there should be more explanation given to the (to me) bizarre finding that a 7 or 9 base guide can cut at the +10/11 position...which of course does not have a guided complement. How do the authors think this can happen?</p>
<p>
<italic>Answer:</italic>
</p>
<p>
<italic>As the reviewer comments the ability of CbAgo to cut with low efficiency tDNA using guides so small that their 3’ end do not reach the catalytic residue  in the protein where the cut is carried out was  a surprising  feature ( at least  11mer pairing would be needed as deduced from the structure in Hedge et al).   Under our experimental conditions 5’-phosphorilated guides of 11 or more nucleotides are very efficient triggering the enzyme activity at complementary 10/11 position of the tDNA (Fig. 8).  Smaller P-guides of 9 and even of 7 mer are still able to direct the enzyme to the expected cutting site, but with much lesser efficiency (Fig  8).  The explanation that we find for this is that the small 5’-P- guides are also efficiently recognized by the MID domain of the protein and used to screen for complementarity. Once found (in a context without any other competing DNA) these small gDNAs could function as seed to position the tDNA  near to the active site of the PIWI domain. Likely through thermodynamic movements, the target DNA eventually reach the catalytic domain in a sort of pendulum movement leading to the observed residual activity.  This explanation has been included in the text for clarification </italic>
</p>
<p> 4.            The authors mention the Hegge at al., preprint, which they should, but that paper was published in NAR after this study. And importantly, so was another study with CbAgo, from a strain mentioned here (Kuzmenko et al). In this study, the authors show several things at odds with the current work: no cleavage with 10 or 12-base guides even after 24hr incubation, activity to 60C, ability to use 5'-OH guides, the ability to cut dsDNA with opposite strand guides at 37C in 1-4h, and with moderate (500 nM) concentrations of CbAgo a chopping activity on plasmid DNA. It is likely this work was not available at the time the reviewed study was published, but it is difficult to ignore the contradictions now. It is possible that the Cb/CbcAgo protein is exactly the same in all 3 studies, and these discrepancies are significant for the conclusions presented here.</p>
<p>
<italic>Answer:</italic>
</p>
<p>
<italic>As the reviewer indicates the article preprint by Kuzmenko was not available when the present article was sent for publication. The revised version includes the actual publication of both articles by Hegge et al and Kuzmenko et al in Nucleic Acids Research, both dealing with the same version of the CbAgo protein.</italic>
</p>
<p>
<italic>The main discrepancies between our work and those mentioned above  (which also show discrepancies between them) are the minimum size of the guides required for efficient cutting, smaller in our work,  and the requirement for 5’-phosphorilation of our guides for efficient activity, and both are likely related.</italic>
</p>
<p>
<italic>
<underline>Phosphorilation of the guides:</underline>
 In the referred articles the use of 5’OH-gDNA under their experimental conditions allows the cutting of tDNA by CbAgo at lower efficiency than with phosphorylated guides (actually  suggesting that the natural function for these proteins could require phosphorylated guides), whereas under our experimental conditions the CbcAgo protein was basically inactive at using 5’ OH-guides  of 20 and 21 mer compared to the phosphorylated ones.  The reasons underlying this difference could be related  differnte and likely concurrent experimental differences. First, our gDNA hibridizes at the 3’ extreme of the tDNA instead of acting in the middle of the target as in Kuzmenko et al.  Second,  the size of the tDNA could also have an effect, as suggested by  supplementary figure 4 of the article by Hegge et al in which a 5’OH guide does not cut a 45 mer target (identical in size to that used in our experiments), whereas it functions with a tDNA of 120 mer. Third, differences in the sequence of the CbAgo (used in Heddge and Kuzmenco works) and CbcAgo proteins (12 amino acid positions) or in their affinity taggings (Strep-tag in our work, His-tag in Kuzmenko´s and no tags in Heddge) could have effects on their performance. In any case, as commented above preference for 5’P guides for CbcAgo is clear in all the cases, and could be significant regarding its actual function in a cell context.</italic>
</p>
<p>
<italic>
<underline>Minimum size of the guides:</underline>
  The preference for 5’P guides by CbcAgo under our experimental conditions  could also be the basis for  experimental discrepancies regarding the minimum guide size to direct the protein, as in our experiments all our guides were phosphorilated, whereas in the works of Heddge et al the guides are labelled with a large fluorophore (Cy3), and in that of Kuzmenko et al. the guides hybridize in the middle of larger tDNA instead of pairing starting at the 3’ extreme of the tDNAs as we did in our experimental setting. </italic>
</p>
<p>
<italic>
<underline>DNA chopping:</underline>
Another point raised by the reviewer focus on the so called “chopping” activity of the enzyme on double stranded DNA. In our hands, we did not observe any degradative activity on the plasmid used as target  (pMH184) even  after 16 hours of incubation at 37ºC with significant concentrations of CbAgo protein loaded with gDNA (Fig 10) or without gDNA  (experiment not shown). </italic>
</p>
<p>
<italic>
<underline>dsDNA activity:</underline>
Regarding cutting of supercoiled plasmid, it seems clear that nicks were generated using CbcAgo loaded with guides directed to both DNA strands of a supercoiled plasmid, but under our experimental condition we did not detect linearized plasmid, supporting interference between overlapping cutting sites</italic>
</p>
<p> 5.            Related, I'd expect there to be some plasmid chopping given the time and concentrations the authors describe. But no Apo reactions are shown in Figure 10, an important control that is left out. And a comparison of attempts to digest non-supercoiled plasmid would be good for the explanation that dsDNA cannot be accessed w/o supercoiling.</p>
<p>
<italic>Answer:</italic>
</p>
<p>
<italic>As commented above, no chopping was detected in our experiments despite incubation for 16 h at 37ºC with the protein in nmolar ratios 10:1 with the dsDNA plasmid</italic>
</p>
<p> 6.            Minor points, but there are some errors ("xilencyanol", "ImajeJ) and inconsistencies (PfAgo/PfuAgo) that should be fixed.</p>
<p>
<italic>Answer:</italic>
</p>
<p>
<italic>Corrected in the revised form</italic>
</p>
</body>
</sub-article>
</sub-article>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C66 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 000C66 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Pmc
   |étape=   Curation
   |type=    RBID
   |clé=     PMC:6961421
   |texte=   DNA interference by a mesophilic Argonaute protein, CbcAgo
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i   -Sk "pubmed:32055395" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021